Description
Class C07J : STEROIDS
Subclass 19/00: Normal steroids containing carbon, hydrogen, halogen, or oxygen, substituted in position 17 by a lactone ring
C07J 19/00
Sub-Class
Stats
- 22 US PATENTS IN FORCE
- 3 US APPLICATIONS PENDING
- 14 Total Patent Owners
- 180 TOTAL INVENTORS
Recent Patents
| Patent # | Title | Filing Date | Issue Date | Patent Owner |
|---|---|---|---|---|
| 11634452 | Compounds for treating neurodegenerative disorders | Dec 11, 17 | Apr 25, 23 | Ethnodyne; Centre National De La Recherche Scientifique (CNRS); |
| 11325940 | Certain chemical entities, compositions, and methods | Oct 08, 19 | May 10, 22 | NeuPharma, Inc. |
| 11091510 | Crystal characteristics, preparation processes and anticancer applications of 17beta-neriifolin crystal forms | Nov 19, 19 | Aug 17, 21 | ENKANG PHARMACEUTICALS (GUANGZHOU), LTD.; ENZHI (GUANGZHOU) PHARMACEUTICALS LIMITED; ENZYNOMICS (H.K.) LIMITED; FOSHAN INTELGEN PHARMACEUTICAL CO. LTD.; |
| 11036131 | Resist composition, method of forming resist pattern, and compound | Dec 19, 18 | Jun 15, 21 | Tokyo Ohka Kogyo Co. LTD |
| 10925887 | Steroid saponins with anti-cancer activity | Feb 09, 18 | Feb 23, 21 | Not available |
| 10766920 | Certain chemical entities, compositions, and methods | May 30, 19 | Sep 08, 20 | NeuPharma, Inc. |
| 10668094 | Selective inhibitors of Alpha2-containing isoforms of Na,K-ATPase and use thereof for reduction of intraocular pressure | Jul 19, 16 | Jun 02, 20 | Yeda Research and Development Co. Ltd. |
| 10487108 | Certain steroids and methods for using the same in the treatment of cancer | May 04, 17 | Nov 26, 19 | NeuPharma, Inc. |
| 10344048 | Certain chemical entities, compositions, and methods | Oct 04, 16 | Jul 09, 19 | NeuPharma, Inc. |
| 10065986 | Certain chemical entities, compositions, and methods | Feb 19, 16 | Sep 04, 18 | NeuPharma, Inc. |
| 9938316 | Selective inhibitors of α2 isoform of Na,K-ATPase and use thereof for reduction of intra-ocular pressure and as cardiotonic agents | Aug 27, 14 | Apr 10, 18 | Yeda Research and Development Co. Ltd. |
| 9676813 | Certain steroids and methods for using the same in the treatment of cancer | Apr 29, 13 | Jun 13, 17 | NEUPHARMA, INC. |
| 9670247 | Contraceptive agents | Jul 01, 13 | Jun 06, 17 | UNIVERSITY OF KANSAS, REGENTS OF THE UNIVERSITY OF MINNESOTA, |
| 9505798 | Steroid compounds as RORyt modulators and uses thereof | Nov 28, 11 | Nov 29, 16 | MEMORIAL SLOAN-KETTERING CANCER CENTER, NEW YORK UNIVERSITY, |
| 9493503 | Certain chemical entities, compositions, and methods | Feb 01, 12 | Nov 15, 16 | NEUPHARMA, INC. |
| 9340570 | Certain chemical entities, compositions, and methods | Apr 29, 13 | May 17, 16 | NEUPHARMA, INC. |
| 9084800 | Indolealkylamino-withasteroid conjugates and method of use | Nov 05, 12 | Jul 21, 15 | Natreon, Inc. |
| 9018197 | Tetradecahydro-1H-cyclopenta[a]phenanthrene compounds, compositions, and related methods of use | Aug 26, 11 | Apr 28, 15 | SUZHOU NEUPHARMA CO., LTD. |
| 8962602 | Anticancer steroidal lactones unsaturated in position 7 (8) | Apr 26, 11 | Feb 24, 15 | PHARMA MAR, S.A. |
| 8937058 | 17-hydroxy-19-nor-21-carboxylic acid-steroid γ-lactone derivative, use thereof, and medicament containing the derivative | Dec 23, 08 | Jan 20, 15 | BAYER INTELLECTUAL PROPERTY GMBH |
Recent Publications
| Publication # | Title | Filing Date | Pub Date | Patent Owner |
|---|---|---|---|---|
| 2024/0417,425 | CARDIAC STEROID DERIVATIVES | Dec 12, 22 | Dec 19, 24 | Not available |
| 2024/0166,684 | COMPOUNDS FOR ALTERING LEVELS OF ONE OR MORE NKA ALPHA SUBUNITS AND THEIR USE IN TREATING PRION DISEASES OR BRAIN DISEASES ASSOCIATED WITH CELLULAR PRION PROTEIN | Mar 10, 22 | May 23, 24 | Not available |
| 2024/0002,428 | STORAGE STABLE CAGED HAPTENS | Jul 10, 23 | Jan 04, 24 | Not available |
Top Owners in This Subclass
| Upgrade to the Professional Level to view Top Owners for this Subclass.Learn More |
|---|
Patents Issued To Date - By Filing Year
Average Time to Issuance
- 32 Months (last 2 years Issuances)
- 32 Months (last 5 years Issuances)